NantKwest(NK)

32.49 0.00 0.0%

今开:0.0昨收:32.49
最高:0.0 最低:0.0
涨停价:0.0跌停价:0.0
总市值:3.552605177E9

NantKwest的最新讨论

合作开发通用实体瘤NK样细胞疗法,新锐B轮融资超5亿

医麦客2023-02-19 07:37

2023年2月19日/医麦客新闻 eMedClub News/--近日,临床阶段公司GAIA BioMedicine宣布和TreeFrog Therapeutics合作,利用TreeFrog 的C-Stem™技术大规模扩增针对实体瘤的同种异体NK样细胞,进而解决NK样细胞的供应难题。早在2021年,TreeFrog Therapeutics完成了7500万美元的B轮融资以推进C-Stem:...查看全文

资本主义拉美行不通2022-05-11 09:16

回复@进雪球做方丈: 制造业占比高的国家,你可以拉个清单看看都是些什么国家。Industry (including construction), value added (% of GDP) | Data (worldbank.org){Industry (including construction), value added (% of GDP) | Data (worldbank.org)}
网页链接查看全文

1 2 3 4 5 6 7 8

NantKwest的公告

$NantKwest(NK)$ 8-K Current report, item 1.01 Accession Number: 0001193125-20-228341  Act: 34  Size: 19 KB 网页链接

$NantKwest(NK)$ 内部交易: 2020-08-19,Director,Thomas John C ,卖出,20000普通股, $9.19

$NantKwest(NK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-047941  Size: 5 KB 网页链接

$NantKwest(NK)$ 内部交易: 2020-08-11,Director,Cohen Cheryl ,卖出,30000普通股, $9.96

$NantKwest(NK)$ 内部交易: 2020-08-13,Director,Thomas John C ,卖出,40000普通股, $9.42

$NantKwest(NK)$ 内部交易: 2020-08-11,Director,Thomas John C ,卖出,20000普通股, $10.35

$NantKwest(NK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-046675  Size: 5 KB 网页链接

$NantKwest(NK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-046677  Size: 10 KB 网页链接

$NantKwest(NK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-046606  Size: 9 KB 网页链接

$NantKwest(NK)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001193125-20-214976  Act: 33  Size: 58 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22